$1.06
-0.01-0.93%
Pre-Market: 8:42 AM EDT
Comments
Loading...
Allarity Therapeutics (NASDAQ:ALLR) Stock, Earnings Estimates, EPS, And Revenue
Allarity Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 7
EPS Estimate
$-8.100
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Allarity Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Allarity Therapeutics (ALLR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-7.71 | $-8.40 | 8.21 % |
| Q2 | 2024-08-05 | $-0.11 | $-0.29 | 62.1 % |
| Q4 | 2024-03-08 | $-6.80 | $-5.00 | -36.0 % |
| Q3 | 2023-11-14 | $-44.80 | $-163.40 | 72.6 % |
Allarity Therapeutics (ALLR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Allarity Therapeutics (NASDAQ:ALLR) reporting earnings?
Allarity Therapeutics (ALLR) is scheduled to report earnings on March 7, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Allarity Therapeutics (NASDAQ:ALLR)?
The Actual EPS was $-7.71, which beat the estimate of $-8.40.
What were Allarity Therapeutics’s (NASDAQ:ALLR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.